T1	Treatment 88 187	primary percutaneous transluminal coronary angioplasty versus tissue plasminogen activator therapy.
T2	Treatment 333 433	tissue plasminogen activator (tPA) or primary percutaneous transluminal coronary angioplasty (PTCA).
